Navigation Links
LABS, Inc. Announces HCT/P ZIKA Virus Screening of Living Donors
Date:4/26/2017

LABS, Inc. (LABS) announced in December 2016 that two new Zika Virus (ZIKV) test offerings were added to its extensive test menu: Nucleic Acid Testing (NAT) for ZIKV; and Enzyme Immunoassays (EIAs) specific for IgM and IgG ZIKV antibodies. At that time, LABS was only able to offer NAT screening for blood donors under an Investigational New Drug (IND) study protocol.

Now, as part of an ongoing commitment to enabling customers’ safe and timely decisions by delivering the highest quality, most accurate laboratory services, LABS is pleased to announce a third ZIKV test offering. LABS is participating in a second IND, with Grifols, a leader in the lab assay market, which will encompass HCT/P screening of living, or “heart-beating” donors. The results are to be used for Investigational Use Only and are not to be used to aid in diagnosis. While the healthcare community awaits final FDA Guidelines, this IND ZIKV option is intended to provide LABS customers with the most up-to-date products and services. If your organization is interested in ZIKV testing, please contact LABS.

For additional information about ZIKV, please visit the U.S. Food and Drug Administration or Centers for Disease Control and Prevention.

About LABS, Inc.
Founded in 1978, LABS provides laboratory services specialized for transplantation and biomedical applications. Our mission is to enable customers’ safe and timely decisions by delivering the highest quality, most accurate laboratory services. We hold an extensive list of registrations, accreditations and licensures including the American Association of Blood Banks (AABB), Clinical Laboratory Improvement Amendments (CLIA), and the U.S. Food and Drug Administration (FDA). We combine our industry-leading credentials with a customer consultative approach to deliver precisely what’s needed, when and how it’s needed. As a result, our customers are able to make safe, informed and prompt decisions that impact their business, and the lives of those they serve. At LABS, we look beyond the testing to what is possible as the result of it. Lives are at stake, innovation is impacted and potential is effected. What we do matters, but what our customers do with it matters even more. LABS. Realize the potential. For more information, please visit our website.

Read the full story at http://www.prweb.com/releases/2017/04/prweb14278908.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Calvert Labs, Inc. Announces Key Appointment
2. GlassesOff Inc. Renamed InnoVision Labs, Inc., New Trading Symbol INVS
3. Neogenis Labs, a World Leader in Nitric Oxide Innovation, Named to Inc. 5000 Fastest Growth Company List
4. DNA Diagnostics Center, One of The Worlds Largest DNA Testing Labs, Celebrates Their 20th Anniversary
5. CannLabs, Inc. to Create Custom Content Channel on theCannabist.co
6. Michele Rickard Appointed to Vice President- Quality and Continuous Improvement at UAS Labs, The Probiotic Company
7. Labs, Industry Join Forces to Train Cyber Defenders for Nation's Critical Cyber Infrastructure
8. SAGE Labs, Inc. Licenses CRISPR/Cas9 genome engineering technology from Caribou Biosciences, Inc.
9. MSP Corporation Announces a New Breakthrough in Monodisperse Droplet Generation
10. Optofluidics Announces Name Change to Halo Labs
11. Nobilis Therapeutics Announces Completion of Landmark NBTX-001 Clinical Trial in 81 Patients with Panic Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... 2017 , ... Stratevi, a boutique firm that partners with healthcare companies to ... an office in downtown Boston at 745 Atlantic Ave. , “We are seeing ... evidence on the value they provide, not just to patients, but also payers. Having ...
(Date:5/22/2017)... , ... May 22, 2017 , ... ... that it is exhibiting in booth B2 at the Association for Pathology ... 22-25. , In addition to demonstrating its Cancer Diagnostic Cockpit and Consultation ...
(Date:5/21/2017)... ... May 20, 2017 , ... CNSDose is ... trial and error process by finding the right antidepressant faster. CNSDose speeds ... doctor-patient relationship through a personalized approach to treatment. , A peer-reviewed ...
(Date:5/19/2017)... ... May 19, 2017 , ... The University City Science ... technologies ripe for commercialization, and who are affiliated with the 21 partner academic ... proposals. QED, now in its tenth round, is the first multi-institutional proof-of-concept program ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:3/30/2017)... 2017  On April 6-7, 2017, Sequencing.com will host ... hackathon at Microsoft,s headquarters in Redmond, ... on developing health and wellness apps that provide a ... Genome is the first hackathon for personal genomics ... companies in the genomics, tech and health industries are ...
Breaking Biology News(10 mins):